News


All News

Richard Winkelmann, M.D., a physician and pioneering dermatology and pathology researcher at the Mayo Clinic, died of pancreatic cancer at his home in Rochester recently. He was 88.

Recently developed biologic therapies developed for treating rheumatoid arthritis are not associated with an increased risk of cancer, according to investigators from the University of Texas MD Anderson Cancer Center.

Patients who undergo an interactive education program, including skin self-examination (SSE) tutorials and telecommunications reminders, are more likely to identify melanoma, according to a recently published study.

Valeant Pharmaceuticals has agreed to buy Medicis Pharmaceutical in a deal valued at about $2.6 billion. The transaction is expected to close in the first half of 2013.

Destination Unknown : Accountable care organizations & similar shared-savings models likely will impact dermatologists’ role in healthcare, but to what extent remains largely uncertain RNA & UV rays : Research sheds light on the inflammatory mechanism of sunburn Clinical Dermatology : Once-daily application of brimonidine tartrate gel safe, effective for facial erythema of rosacea Cosmetic Dermatology : Glycans and glycobiology emerge in development of anti-aging skincare products Cutaneous Oncology : AJCC’s melanoma staging system elicits debate among dermatologists Practice Management : Successful outsourcing can improve patient throughput, lower staffing costs

About 76,000 new cases of invasive melanoma occur in the United States each year, according to the American Cancer Society, and patients who have had one melanoma have a 5 to 10 percent risk of developing another primary tumor during their lifetime. As a result of this increased melanoma risk, careful follow-up of these patients is critical, a Harvard clinician advises.

Although dermatologic conditions most apparently affect the skin, dermatologists commonly encounter three types of psychodermatologic disorders where the mind and skin may interact, according to John Koo, M.D., professor and vice chairman, department of dermatology, University of California, San Francisco Medical Center.

Dermatologist Joe Psoriasis is known throughout the country as an expert in the treatment of psoriasis. An inherent risk of treating such challenging patients is the higher risk of medical malpractice lawsuits. Dr. Psoriasis has now had five such lawsuits filed against him. He is contemplating discontinuing this portion of his practice. Will the HEALTH Act of 2011 provide him with more protection from such lawsuits?

While the incidence of melanoma is lower among African-Americans than it is among Caucasians, mortality due to melanoma is higher among the former. The reason, experts say, is because skin cancers in African-Americans appear on sites where they behave more aggressively, and there is a delay in diagnosis with this patient population.

Ultraviolet B (UVB) radiation damage to noncoding RNAs in keratinocytes initiates a cascade of events leading to the release of tumor necrosis factor-alpha (TNF-alpha), a cytokine central to the inflammatory skin response commonly known as sunburn. The surprising discovery of this mechanism has potential implications for better understanding of prevention, carcinogenesis and phototherapy, researchers say.

Barbara Mathes, M.D., started her healthcare career as an emergency room nurse. She remembers answering medical residents' questions, and the residents would tell her she might as well go into medicine. Her reply? "One day I think I will." So started a multifaceted professional life in dermatology, which has included private practice, teaching, industry work, research and more.

Eight years after the Women's Health Initiative (WHI) linked estrogen supplementation to breast cancer and heart disease, the impact of estrogen withdrawal is obvious in a less-than-obvious location; hormone-deficient vulvar disease is becoming more common, according to F. William Danby, M.D.